80 Results for "

Prostatic hyperplasia

" in MedChemExpress (MCE) Product Catalog:
Products (80)

80 Results for "Prostatic hyperplasia" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-B0371F
CAS No.: 63074-08-8
Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-B0371
CAS No.: 63590-64-7
Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-B0371A
CAS No.: 70024-40-7
Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13635
CAS No.: 98319-26-7
Purity:  99.97%
Synonyms: MK-906
Research Areas:  

Cancer

Finasteride (MK-906) is an orally active and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0661
CAS No.: 106133-20-4
Synonyms: (R)-(-)-YM12617 free base; LY253351 free base
Tamsulosin ((R)-(-)-YM12617 free base) is an orally active antagonist of α1-adrenergic receptor. Tamsulosin induces Apoptosis. Tamsulosin is used for the research of prostatic hyperplasia. Tamsulosin attenuates abdominal aortic aneurysm growth and inhibits inflammation in animal models .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0661A
CAS No.: 106463-17-6
Synonyms: (R)-(-)-YM12617; LY253351
Tamsulosin hydrochloride ((R)-(-)-YM12617 free base) is an orally active antagonist of α1-adrenergic receptor. Tamsulosin hydrochloride induces Apoptosis. Tamsulosin hydrochloride is used for the research of prostatic hyperplasia. Tamsulosin hydrochloride attenuates abdominal aortic aneurysm growth and inhibits inflammation in animal models .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107385
CAS No.: 119169-78-7
Purity:  99.96%
Synonyms: ONO-9302; SKF105657
Target:  

5 alpha Reductase

Research Areas:  

Cancer

Epristeride (ONO-9302) is a selective, specific and orally active uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2. Epristeride has inhibitory effects for SR isoenzymes types 2 with Ki value of 0.7-2 nM. Epristeride can be used for the research of prostatic hyperplasia and acne .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0192
CAS No.: 81403-80-7
Synonyms: SL 77499
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0192A
CAS No.: 81403-68-1
Synonyms: SL 77499-10
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

Alfuzosin (SL 77499-10) hydrochloride is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin hydrochloride relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin hydrochloride can be used in study of benign prostatic hyperplasia (BPH) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0391
CAS No.: 57149-07-2
Synonyms: KT-611; BM-15275
Target:  

Adrenergic Receptor

Naftopidil (KT-611) is is a selective alpha1-adrenoceptor antagonist, with Kis of 3.7 nM, 20 nM and 1.2 nM for the cloned human α1a-, α1b- and α1d-adrenoceptor subtypes, respectively. Naftopidil has antiproliferative effects. Naftopidil can be used for the research of prostate hyperplasia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101336
CAS No.: 169505-93-5
Purity:  99.93%
RS 17053 hydrochloride is a selective α1A-adrenoceptor antagonist. RS 17053 hydrochloride binds to MrcA/MecA A-class penicillin-binding proteins, inhibits peptidoglycan biosynthesis, and binds to α1A and α1B/α1D-adrenoceptors. RS 17053 hydrochloride disrupts bacterial membranes, causing depolarization, ATP depletion, protein leakage, ROS accumulation, and upregulation of stress response genes. RS 17053 hydrochloride exerts bactericidal activity against Gram-positive/Gram-negative pathogens. RS 17053 hydrochloride can be used for research on bacterial infections and benign prostatic hyperplasia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N13015
CAS No.: 34199-21-8
Quercetin 5-O-β-D-glucopyranoside is a glycosylated flavonoid metabolite and flavonoid compound. Quercetin 5-O-β-D-glucopyranoside can be produced by microbial transformation of Quercetin (HY-18085) via Mucor hiemalis. Quercetin 5-O-β-D-glucopyranoside can be used in studies related to benign prostatic hyperplasia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0391B
CAS No.: 1164469-60-6
Synonyms: KT-611 hydrochloride; BM-15275 hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Cancer

Naftopidil hydrochloride (KT-611 hydrochloride) is a selective alpha1-adrenoceptor antagonist, with Kis of 3.7 nM, 20 nM and 1.2 nM for the cloned human α1a-, α1b- and α1d-adrenoceptor subtypes, respectively. Naftopidil hydrochloride has antiproliferative effects. Naftopidil hydrochloride can be used for the research of prostate hyperplasia .
loading...
    loading...
Cat. No.: HY-115450
CAS No.: 856689-51-5
Purity:  99.43%
Target:  

LPL Receptor

Research Areas:  

Endocrinology Cancer

ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with Kd of 0.34 nM (37 °C, 2 h). ONO-0300302 can be used for benign prostatic hyperplasia (BPH) research .
loading...
    loading...
Cat. No.: HY-158498
Synonyms: FA2 N-linked oligosaccharide; F(6)A2 glycan
FA2 glycan (G0F) (FA2 N-linked oligosaccharide; F(6)A2 glycan) is a core-fucosylated biantennary N-linked oligosaccharide that serves as a prostate cancer biomarker. The level of FA2 glycan (G0F) is higher in prostate cancer than in benign prostatic hyperplasia, and it is further elevated in advanced prostate cancer with a Gleason score ≥8 compared with both benign prostatic hyperplasia and low-/intermediate-risk prostate cancer. FA2 glycan (G0F) can be used in prostate cancer research .
loading...
    loading...
Cat. No.: HY-P3501
CAS No.: 492447-54-8
Synonyms: NX-1207
Target:  

Apoptosis

Research Areas:  

Cancer

Fexapotide (NX-1207) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research .
loading...
    loading...
Cat. No.: HY-103204
CAS No.: 1215654-26-4
Purity:  99.57%
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

RS100329 hydrochloride is a potent and selective α1A-adrenoceptor antagonist with pKi values of 9.6, 7.9 and 7.5 for α1A, α1D, and α1B, respectively. RS100329 hydrochloride inhibits reflex urethral contractions. RS100329 hydrochloride can be used in research of benign prostatic hyperplasia .
loading...
    loading...
Cat. No.: HY-153528
CAS No.: 73671-86-0
Synonyms: DMAA; 4-MA
17β-N,N-Diethylcarbamoyl-4-methyl-4-aza-5α-androstan-3-one (DMAA; 4-MA) is a 5α-reductase inhibitor with a Ki of 5.3 nM. 17β-N,N-Diethylcarbamoyl-4-methyl-4-aza-5α-androstan-3-one inhibits the NADPH-dependent conversion of testosterone to 5α-DHT through competitive binding to the testosterone site, and inhibits both the membrane-bound and solubilized forms of the enzyme. 17β-N,N-Diethylcarbamoyl-4-methyl-4-aza-5α-androstan-3-one partially inhibits prostatic epithelial 3β-hydroxysteroid oxidoreductase and inhibits prostatic cytosolic androgen binding. 17β-N,N-Diethylcarbamoyl-4-methyl-4-aza-5α-androstan-3-one reduces prostatic 5α-dihydrotestosterone and elevates testosterone in vivo, inhibits androgen-dependent prostate and seminal vesicle growth, reduces prostate volume, and inhibits the growth of androgen-dependent prostate tumors. 17β-N,N-Diethylcarbamoyl-4-methyl-4-aza-5α-androstan-3-one can be used in research related to benign prostatic hyperplasia and prostate cancer .
loading...
    loading...
Cat. No.: HY-N8850
CAS No.: 83199-38-6
Angelol G, a coumarin, can be isolated from Campylotropis hirtella. Angelol G shows inhibitory activity for prostate specific antigen (PSA)IC50 value of 152.1μM. Angelol G can be used for the research of benign prostate hyperplasia (BPH) .
loading...
    loading...
Cat. No.: HY-B0371S
CAS No.: 1006718-20-2
Terazosin-d8 is deuterium labeled Terazosin. Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment .
loading...
    loading...